Macular Edema

Healio’s top FDA articles in ophthalmology this year included updates on the Vabsymo prefilled syringe, two new aflibercept biosimilars and an oral therapy for Stargardt disease.

CHICAGO — In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Michael S. Ip, MD, discusses the available treatments for nonproliferative diabetic retinopathy.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Dilraj Grewal, MD, FASRS, of Duke Eye Center shares real-world data on suprachoroidal triamcinolone acetonide for noninfectious uveitis with macular edema.

The European Commission approved Vabysmo for the treatment of visual impairment due to macular edema secondary to retinal vein occlusion, according to a press release from Roche.

The FDA approved Yesafili and Opuviz as the first interchangeable biosimilars to Eylea, according to a press release from the FDA.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Riad Sherif, MD, CEO of Oculis, discusses the company’s two phase 3 clinical trials for the OCS-01 eye drop.

Patients with neovascular age-related macular degeneration experienced visual benefits and anatomic improvements with extended dosing intervals of IBI302, according to a press release from Innovent Biologics.

A 39-year-old woman was referred to the New England Eye Center complaining of new-onset intermittent “muddy” spots in her vision. She had no associated vision loss, flashes, floaters or eye pain.